Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASSIST: HSCT vs Pulse Cyclophosphamide in Systemic Scleroderma
NCT00278525Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Sep 2005
- Primary completion
- Sep 2011
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cyclophosphamide and antithymocyte globulin rabbit in systemic sclerosis (SSc), sponsored by Northwestern University. Started Sep 2005; status: completed.
02
Drugs
cyclophosphamideantithymocyte globulin rabbit
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT00278525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00278525.